Cures Within Reach for Cancer: Founder Bios
Dr. Laura Kleiman
Executive Director of Cures Within Reach for Cancer, and Scientific Research Director of the cBio Center at the Dana-Farber Cancer Institute. Previously she was Project Manager at the drug repurposing non-profit GlobalCures, where she initiated a multicenter Phase III cancer clinical trial. Laura earned her PhD in Computational and Systems Biology from MIT. She was an American Cancer Society Postdoctoral Fellow at the Massachusetts General Hospital and Harvard Medical School, where she conducted translational cancer research. She has also performed research at Rutgers University and the Fred Hutchinson Cancer Research Center. Laura has authored peer-reviewed journal articles and book chapters on understanding and treating cancer and has given talks internationally on her work.
Contact Laura: firstname.lastname@example.org
Dr. Dale Flanders
Director of Strategic Development at Cures Within Reach for Cancer. Dale first learned about repurposing of FDA-approved non-cancer drugs for cancer treatment through GlobalCures, and he is now committed to finding innovative approaches to their funding and development. Dale received his PhD in electrical engineering from MIT in 1978. He is a successful entrepreneur with a long track record of defining new businesses, raising capital, and building successful and profitable companies at the leading edge of technology. After working in research at MIT Lincoln Laboratory, Dale joined Lasertron as the VP of Engineering and R&D and CTO, and as VP of Device Manufacturing. When Lasertron was eventually acquired by Corning, Dale left to found Axsun Technologies. At Axsun, he served as CEO until 2015 and raised over $150 million of investment. Axsun was acquired by a public company, Volcano Corp., in 2008 and Phillips acquired Volcano and Axsun in 2014. Today Axsun is a growing independent company owned by a private equity firm. Since leaving Axsun, Dale has acted as an adviser to and investor in various startup companies in the medical diagnostics and therapy areas. He is the author of more than 100 issued U.S. patents.
Contact Dale: email@example.com